Search Results - subject:"cost€“benefit"

The economic value of Royal Botanic Gardens, Kew

Oxford Economics Ltd. - 2023

Persistent link: https://www.econbiz.de/10015064915

Study on the allocation of costs and benefits for offshore infrastructure in EU sea basins : final report

Bene, Csinszka (contributor); Moerenhout, Joris (contributor) - European Commission / Directorate-General for Energy; … - 2023

would be installed by 2050. This study supports more coordinated approaches and processes for the planning, cost-benefit … outputs of this study consist of recommendations: 1) for sea basin cost-benefit and cost-sharing options; and 2) for … coordinated cost-benefit analyses and cost allocations of specific offshore electricity transmission and generation investments …

Persistent link: https://www.econbiz.de/10015278930

Study on the allocation of costs and benefits for offshore infrastructure in EU sea basins : final report

Bene, Csinszka (contributor); Moerenhout, Joris (contributor) - European Commission / Directorate-General for Energy; … - 2023

Persistent link: https://www.econbiz.de/10015279019

The benefits and costs of reaching net zero emissions in Latin America and the Caribbean

Kalra, Nidhi; Molina-Perez, Edmundo; Syme, James; … - 2023

Persistent link: https://www.econbiz.de/10014491713

The benefits and costs of international Arts and Design students to the UK economy : report for the University of the Arts London

Cannings, James; Halterbeck, Maike; Conlon, Gavan - 2023

Persistent link: https://www.econbiz.de/10014494253

The benefits and costs of international higher education students to the UK economy : summary report for the higher education policy institute, Universities UK International, and Kaplan International Pathways

2023

Persistent link: https://www.econbiz.de/10014494307

Cost-utility analysis of valsartan, enalapril, and candesartan in patients with heart failure in Iran

Ravangard, Ramin; Jalali, Farideh Sadat; Hajahmadi, Marjan - In: Health economics review 13 (2023) 1, pp. 1-11

Background Today, heart failure is one of the leading causes of death and disability in most developed and developing countries. By 2030, more than 23.3 million people are projected to die of cardiovascular diseases each year, and the prevalence of heart failure is expected to increase by 25%....

Persistent link: https://www.econbiz.de/10014500515

Cost-utility analysis of Palbociclib + letrozole and ribociclib + letrozole versus Letrozole monotherapy in the first-line treatment of metastatic breast cancer in Iran using partitioned survival model

Darvishi, Ali; Daroudi, Rajabali; Fazaeli, Ali Akbar - In: Health economics review 13 (2023) 1, pp. 1-13

Background Palbociclib and Ribociclib are cyclin-dependent kinase 4/6 oral molecular inhibitors that have the potential to improve overall survival (OS), progression-free survival (PFS), and quality of life in patients with metastatic breast cancer (MBC). The objective of this study was to...

Persistent link: https://www.econbiz.de/10014500641

Valuing for sustainability : hidden costs and benefits in multidimensional agriculture

Marangon, Francesco; Bertossi, Alberto; Troiano, Stefania - In: Italian review of agricultural economics 78 (2023) 2, pp. 53-65

The concept of agriculture has changed over the years. Whereas it was once considered simply a "means" for the production of goods (food and non-food), today, its multifunctionality, understood as the ability to also provide environmental and social services, takes on greater importance. The...

Persistent link: https://www.econbiz.de/10014550903

Economic consequences of announcing strategic alternatives : a voluntary disclosure's benefits and costs

Zha Giedt, Jenny - In: Contemporary accounting research : the journal of the … 40 (2023) 4, pp. 2446-2476

Persistent link: https://www.econbiz.de/10014442843